MetoclopramideThird Party Manufacturing in India

Metoclopramide works by blocking dopamine D2 and serotonin 5-HT3 receptors in the chemoreceptor trigger zone (CTZ) of the brain.

Simultaneously, it acts as a prokinetic agent by enhancing the tissue response to acetylcholine in the upper gastrointestinal tract, which increases gastric emptying and intestinal transit. This biological effect helps the body prevent nausea and vomiting while improving gastric motility.

Unlike simple antacids, Metoclopramide provides dual central antiemetic and peripheral prokinetic actions. It is highly effective for patients suffering from chemotherapy-induced nausea, gastroesophageal reflux disease (GERD), and diabetic gastroparesis.

Therapeutic Uses

Metoclopramide is prescribed for the treatment of:

• Nausea and Vomiting: Prevents and treats nausea induced by chemotherapy, surgery, or migraines.
• Diabetic Gastroparesis: Relieves symptoms of delayed gastric emptying, such as bloating and abdominal discomfort in diabetic patients.
• Gastroesophageal Reflux Disease (GERD): Improves lower esophageal sphincter tone to prevent acid reflux.

Why Manufacturers Choose Metoclopramide

Metoclopramide is a cornerstone antiemetic and prokinetic agent with massive demand across primary care and hospital settings. Its established safety profile and essential status make it a high-volume product year-round.

This makes Metoclopramide one of the most sought-after molecules for third party manufacturing in India, with consistent demand from PCD franchise operators, hospital suppliers, and export-oriented companies.